“…Similarly, IFNγ may promote caspase-1-mediated cell killing ( Chin et al., 1997 ) or death receptor-induced apoptosis in some cancer-derived cell lines ( Takeda et al., 2002 ; Tanzer et al., 2017 ; Xu et al., 1998 ). Patients suffering from the pathogen-associated hyper-inflammatory condition, hemophagocytic lymphohistiocytosis (HLH), can benefit from IFNγ blockade ( Locatelli et al., 2020 ), while certain pathogens including Mycobacterium tuberculosis and Legionella pneumophilia have been reported to inhibit IFNγ receptor signaling ( Fortune et al., 2004 ; Kincaid and Ernst, 2003 ; Yang et al., 2020 ). While IFNγ may contribute to the death of infected cells ( Herbst et al., 2011 ; Janssen et al., 2002 ; Niedelman et al., 2013 ; Sedger et al., 1999 ), how IFNγ might invoke immune cell death and the consequences thereof remain incompletely understood.…”